Dr. Kei Suzuki is a thoracic surgeon at Inova in Virginia, USA, Director of Thoracic Surgery at the Schar Cancer Institute, and an Assistant Professor at University of Virginia School of Medicine. Dr. Suzuki studied biological engineering and graduated Cum Laude from Cornell University. He then did his general surgery residency at Beth Israel Medical Center in New York City. During his residency, he took two years off to do a research fellowship at Memorial Sloan Kettering Cancer Center, where he investigated the prognostic role of tumor-immune microenvironment in lung cancer. He then did his cardiothoracic fellowship at Memorial Sloan Kettering Cancer Center and New York Presbyterian. Dr. Suzuki’s research interests include tumor-immune microenvironment and prognostic/predictive markers in lung cancer as well as improving lung cancer screening efforts and he has received several grants. Dr. Suzuki is board certified by American Board of Surgery and American Board of Thoracic Surgery. He also has a medical license in Japan.